Ginkgo Bioworks
DNA
DNA
279 hedge funds and large institutions have $2.74B invested in Ginkgo Bioworks in 2022 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 103 increasing their positions, 57 reducing their positions, and 39 closing their positions.
Holders
279
Holders Change
+17
Holders Change %
+6.49%
% of All Funds
4.82%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
59
Increased
103
Reduced
57
Closed
39
Calls
$35.3M
Puts
$19.4M
Net Calls
+$15.9M
Net Calls Change
+$12.3M
Top Buyers
Top Sellers
| 1 |
GA
1
General Atlantic
New York
|
$101M |
| 2 |
SIG
2
Senator Investment Group
New York
|
$0 |
| 3 |
3
Coatue Management
New York
|
$0 |
| 4 |
4
Goldman Sachs
New York
|
$3.4M |
| 5 |
5
Millennium Management
New York
|
$342K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CS
326
Clear Street
New York
| – | – | – | – |
|
327
CI Investments Inc
Toronto,
Ontario, Canada
| $0 | 54 | – | – |
|
|
CAL
328
Capital Advisors Ltd
Shaker Heights,
Ohio
| $0 | 45 | +45 | New |
|
|
C
329
Covestor
London,
United Kingdom
| $0 | 75 | +75 | New |
|
|
LC
330
Lindbrook Capital
Calabasas,
California
| $0 | 75 | +75 | New |
|
331
AssetMark Inc
Concord,
California
| $0 | 112 | +112 | New |
|